Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
Schlesinger
T E
TE
Department of Dermatology, Cleveland Clinic Foundation, OH, USA.
Camisa
C
C
Gay
J D
JD
Bergfeld
W F
WF
D000328:Adult; D003875:Drug Eruptions / Q000209:etiology / Q000473:pathology; D006526:Hepatitis C / Q000150:complications / Q000628:therapy*; D006521:Hepatitis, Chronic / Q000150:complications / Q000628:therapy*; D006801:Humans; D017488:Hyperkeratosis, Epidermolytic / Q000209:etiology* / Q000473:pathology; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D017676:Lichen Planus, Oral / Q000209:etiology*; D008297:Male; D010241:Parakeratosis / Q000209:etiology; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins